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Abstract
Purpose Gastric bypass surgery has become a relatively
low-risk bariatric surgical intervention in a high-risk patient
population (Nguyen et al., Arch Surg, 141:445–449, 2006;
Buchwald et al. JAMA, 13:1724–1737, 2004). Surgical
interventions in patients suffering from morbid obesity are
typically associated with excess morbidity (Parikh et al.,
Am Surg, 73:959–962, 2007). Though overall mortality
after bariatric surgery is <1% is low (Mason et al., Obes
Surg, 17:9–14, 2007), some surgical complications such as
anastomotic leaks, staple line disruption and bowel ob-
struction may still impact on postoperative outcome (Parikh
et al., Am Surg, 73:959–962, 2007; Mason et al., Obes
Surg, 17:9–14, 2007). Early symptoms are often missed, as
clinical presentation may be discreet, inexistent or falsely
attributed to obesity.
Methods This case report refers to a patient in whom
discomfort and agitation associated with a rise in temper-
ature heralded a fulminant septic shock syndrome precip-
itating his death. Literature on early complications and
management after gastric bypass is reviewed.
Conclusion A high level of suspicion should be present in
the case of an unexpected postoperative deterioration of the
patient’s general condition. Time to treat may be very short
(Mason et al., Obes Surg, 17:9–14, 2007). Computed
tomography is mandatory to rule out pulmonary embolism
and bypass obstruction.
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Case report
After many years of unsuccessful conservative treatment
attempts, a 40-year-old morbidly obese male patient
with a BMI of 69 kg·m−2 (220 kg, 179 cm) was
scheduled for open gastric bypass surgery. The patient
suffered from obstructive sleep apnoea, hypertension and
venous insufficiency with chronic crural ulcer. He fulfilled
the high-risk criteria of the Obesity Surgery Mortality Risk
Score (OS-MRS) [5]. Medication consisted of 5 mg
torasemide/day. Preoperative diagnostics included gastros-
copy, which showed normal findings; whereas pulmonary
function testing revealed a restrictive pattern of respiratory
compromise.
Laboratory findings were all normal and a chest X-ray
showed no abnormality.
Anaesthesia Only ranitidine and metoclopramide were
given as premedication, and a second generation cephalo-
sporin was administered 60 min prior to the start of the
operation. Electrocardiography and pulse oximetry were
completed by continuous blood pressure monitoring via a
radial artery line, which was also used for intermittent
blood gas control. Before anaesthesia, a subclavian central
venous access was established without complication. In
addition, a 20 G multiport epidural catheter was inserted at
midthoracic level (Th7) after having identified the epidural
space at a depth of 14 cm using a 15 cm Tuohy needle.
After a test dose of 0.5% bupivacaine with epinephrine
(1:200 000), epidural anaesthesia was based on an initial
bolus of 0.5% bupivacaine followed by a continuous
infusion of 0.25% bupivacaine at 3–4 ml·h−1. General
anaesthesia was induced with thiopental and fentanyl, and
was maintained with isoflurane. Tracheal intubation was
facilitated by succinylcholine; and intraoperative muscle
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relaxation was achieved by bolus administration of atracu-
rium. Anaesthetic management was uneventful. Intraoper-
ative fluid losses including a urine output of 525 ml and a
blood loss of less than 500 ml were made up for by
administration of 5,700 ml Ringer’s lactate and 500 ml 6%
hydroxyethyl starch over the 210 min of surgery. For
haemodynamic stability a total dose of 20 mg intravenous
ephedrine was administered. At the end of surgery, the
patient’s trachea was extubated as soon as there was
evidence of full recovery of consciousness and spontaneous
breathing.
Surgery After laparotomy by bicostal incision and chole-
cystectomy, a 30 ml gastric pouch was formed. A jejunal
loop was prepared and dissected 50 cm distal to the
ligament of Treitz; and the distal staple line of the jejunum
was covered with a running suture and brought up to the
gastric pouch as alimentary limb retrocolically and ante-
gastrically. A manual side-to-side gastrojejunostomy was
performed with interrupted Maxon 4.0 sutures. Finally, an
end-to-side jejuno-jejunostomy was performed 150 cm
distal to the gastrojejunostomy. All mesenteric defects were
closed to prevent from potential internal hernias. No suction
drains were placed.
Postoperative course The patient spent the first uneventful
postoperative night in the intensive care unit before being
transferred to the ward. On the first postoperative day,
however, a rise in temperature to 38.5°C and an elevated
white blood cell count were interpreted as an inflammatory
response (postaggression syndrome) frequently encountered
during the first 48 h after surgery (Table 1). There was no
clinical evidence of a surgical complication; a control
contrast swallow performed on the following day showed
neither signs of contrast media leakage nor any indication
of functional obstruction of the surgical anastomoses
(Table 2). Therefore, the patient was allowed to drink up
to 500 ml·24 h−1. On postoperative day 2, there was a
further increase in temperature, peaking at 40.4°C, which
was associated with weakness and dyspnoea. Upon phys-
ical examination, the abdomen was soft. In particular, there
was neither abdominal distension nor abnormal tenderness.
Blood samples were taken for culture only (no blood gas
analysis was carried out, Table 3) and the patient was given
oxygen, antipyretics and amoxicillin/clavulanic acid. Addi-
tional intravenous fluids and a single bolus of 10 mg
furosemide were given, resulting in a urinary output of
70 ml·h−1. Within a few hours, progressive haemodynamic
instability developed in absence of overt tachycardia. The
rapidly worsening clinical condition was accompanied by
increasing hypoxemia, continuing restlessness and breath-
lessness culminating in acute cardiorespiratory arrest during
the transfer of the patient to the intensive care unit. ECG
monitoring revealed that sinus tachycardia had turned into
an idioventricular escape rhythm followed by asystole.
Echocardiography and ultrasound during resuscitation
excluded pericardial effusion and showed no signs of acute
right ventricular pressure overload. No intraabdominal or
retroperitoneal fluid was detectable. Despite aggressive
fluid replacement and high dosages of epinephrine the
patient died after almost 30 min of unsuccessful cardiopul-
monary resuscitation.
Autopsy Septic shock was diagnosed as the primary cause
of death. While E. coli was identified in the blood samples
taken shortly before cardiorespiratory arrest, Enterobacter-
iaceae were found in the swabs taken from the spleen
during the autopsy. Two litres of feculent gastric content,
fibrinous peritonitis of the small bowel and some ascites at
the site of the gastric anastomosis were found. However,
there was no evidence of an anastomotic leak. In addition,
there were signs of an acute tracheobronchitis, whereas
pulmonary thromboembolism could be ruled out. Cardiac
findings showed a mild biventricular eccentric hypertrophy
in the absence of any other pathology. In particular, no
atherosclerosis was found.
Discussion
By the year 2040, one in two adults in the United States is
expected to fulfil the criteria of obesity, defined by a body
Table 1 Signs of infection and clinical findings
CRP
(mg·l−1)
WBC
(109·l−1)
Neutrophils
(109·l−1)
Temperature
(°C)
Normal values <10 <10 <6.7 <37
Admission 7 9.3 6.9 37.0
1st POD 8 15.2 13.8 37.0
2nd POD 95 10.6 9.0 38.7
3rd POD – – – 40.4
Legend: POD: postoperative day; WBC: white blood cell count
Table 2 Thrombocytes, glucose levels and drainage via naso-gastric
tube in the first 24 hours after surgery
Tc (109·l−1) Glc (mmol/l) n.g.-tube (ml)
Normal values F 3.8–6.1 –
Admission 248 – –
1st hour after surgery 213 8.9 50
14 h after surgery 192 6.3 0
– – –
Tc Thrombocytes, Glc glucose, n.g.-tube naso-gastric tube
574 Langenbecks Arch Surg (2009) 394:573–577
mass index (BMI) above 30 kg·m−2, assuming that the
present global trend of increasing prevalence of obesity
persists over the coming decades [6]. Obesity is a disease
which is associated with numerous comorbidities that
reduce life expectancy if left untreated [7–9]. As a
consequence, this has important economic implications for
health care systems worldwide [10]. The results of surgical
treatment of morbid obesity are by far more promising than
those of conservative therapeutic approaches [11]. Bariatric
surgery reduces not only morbidity but also mortality, as
has been recently shown [7, 8]. Data provided by the
American Society for Metabolic and Bariatric Surgery
indicate that approximately 150,000 patients in the US
underwent some form of surgery for obesity in 2004 [12].
This figure corresponds to a nearly six-fold increase since
1990. In a review of more than 18,000 gastric bypass
operations, overall mortality has been reported to be as low
as 0.24% [4]. Nevertheless, some surgical complications
such as anastomotic leaks, staple line disruption and bowel
obstruction may still impact on postoperative outcome [3,
4]. Early symptoms of these complications are often
missed, as clinical presentation may be discreet, inexistent
or falsely attributed to obesity, as in our patient. Furthermore,
time to treat (TTT) is very short in some typical causes of
death after gastric bypass surgery [4]. In our case, in the
absence of ominous radiographic findings in the postoper-
ative control images and showing no symptoms suggestive
of peritonitis, the rise in temperature accompanied by
tachypnea and restlessness were attributed to a pulmonary
rather than an abdominal complication. Thus, misinterpre-
tation of the worsening clinical condition and failure to
recognise tachypnea as a criterion of systemic inflammatory
response syndrome (SIRS) potentially caused a delay in
transfer to intensive care. Furthermore, clinical signs of
peritonitis may be overlooked in morbidly obese patients
and even more so in the presence of epidural analgesia.
Pulmonary embolism associated with an undiagnosed
deep venous thrombosis was considered to be the most
probable pathophysiology underlying the acute cardiovas-
cular collapse. In fact, at a rate of 30%, pulmonary
embolism was the leading cause in a multicenter series of
93 cases of death after gastric bypass surgery, while a
gastrointestinal leak accounted for 14%, peritonitis without
a leak for 11%, heart failure for 12%, haemorrhage for 7%,
and bypass obstruction for 5%, respectively [4]. Even in
patients receiving low molecular weight heparin prophy-
laxis, lethal thromboembolism can never be ruled out with
certainty [13]. In addition, a number of mediators released
from metabolically active adipose tissue are apparently
linked to a prothrombotic and proinflammatory state [14,
15]. Of note, the production and release of cytokines such
as TNF-alpha and interleukin-6 from adipose tissue appears
to be relevant for the pathophysiology underlying a broad
array of comorbidities. As of now, the roles of these and
other secretory products of adipose tissue and their
relationship to inflammation in obesity are poorly under-
stood and are the focus of ongoing research [16].
In our case, autopsy did not reveal a clear cause for the
septic shock syndrome. Despite the absence of a typical
anastomotic leak, the presence of feculent fluid in the
gastric remnant in association with localized fibrinous
peritonitis and ascites is suggestive of a microscopic leak
as most probable cause of death in presence or absence of
an underlying bypass obstruction. Bypass obstruction is one
of the most urgent surgical complications, and the time to
treat may be extremely short. The risk of fatal outcome
within a lag of only 2 days after gastric bypass surgery is a
matter of concern [4]. Even peritonitis in absence of a leak
(with similar symptoms as in a microscopic leak) has been
described as cause of death [4]. The issue should be raised
as to whether and to what degree obesity contributed to the
magnitude of sepsis triggered by a minor surgical compli-
cation. Whenever a patient deteriorates after gastric bypass
surgery and the cause is not clear, clinical evaluation should
be supplemented by computed tomography of the thorax
and abdomen in order to rule out pulmonary embolism and
bypass obstruction.
A multidisciplinary approach is paramount for preoper-
ative risk stratification [5, 17]. Risk factors that may modify
the perioperative course should be identified during
preoperative assessment and include laboratory screening,
a pulmonary function test and echocardiography, if appro-
priate. Low-molecular-weight heparin prophylaxis for
thromboembolism should be administered before surgery
[18]. Compression stockings with or without sequential
dynamic function may confer an additional benefit [19].
Table 3 Blood gas analysis
Normal i.o. 1st hour i.o. 4 hours p.o. 1st hour p.o. 14 hours
pH 7.38–7.42 7.36 7.36 7.36 7.42
Bicarbonate 21–26 mmol/l 22.4 20.9 20.5 24.7
Base Excess −2.4–2.3 mmol/l −2.5 −3.7 −3.9 0.8
pCO2 5.0–5.5 KPA 5.4 5.0 4.9 5.2
pO2 >10.7 KPA 16.1 20.5 9.3 9.6
Lactate <1.8 1.9 3.7 4.6 1.3
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For perioperative blood pressure and blood gas monitor-
ing, a radial arterial line should be used in extremely obese
patients in whom non-invasive blood pressure monitoring—
even if extra wide cuffs are used—is often unreliable. A
central venous catheter should be used in patients whose
peripheral veins are difficult to access. Blood volume status
should be checked by hourly urine output monitoring and
careful assessment of perioperative volume changes; since
central venous pressure monitoring is unreliable in the
presence of pneumoperitoneum and anti-Trendelenburg
positioning. Bispectral index (BIS) monitoring of depth of
anaesthesia is recommended as a means to tailor drug
administration to the patient’s needs [20].
Both general anaesthesia and obesity have a direct bearing
on the occurrence of postoperative respiratory impairment.
The magnitude of which has been shown to be directly related
to the BMI of patients undergoing laparotomy [21]. There-
fore, administration of perioperative epidural anaesthesia is
recommended as an effective means to reduce the impact of
laparotomy on postoperative pulmonary function and to
enhance postoperative recovery [22]. Obesity is a known risk
factor for aspiration pneumonia resulting from regurgitation,
therefore, administration of an H2 receptor antagonists and/
or metoclopramide is recommended [23]. As obesity is a risk
factor for difficult intubation, equipment for difficult airway
management should be readily available in the operating
room. An awake fiberoptic intubation of the trachea should
be considered whenever preoperative airway assessment
suggests a high probability of a difficult airway [24].
Preoxygenation in a 25° head-up position rather than in
supine position before induction of anaesthesia results in a
23% higher oxygen tension, thus, allowing more time for
intubation and airway control [25, 26]. Similarly, positive
end-expiratory pressure during induction increases the
duration of non-hypoxic apnoea [27]. The volatile anaesthe-
tic desflurane and the opioid remifentanil are recommended
for maintenance of general anaesthesia since both agents
have a very short half-life and are rapidly eliminated [24].
High quality postoperative care is the centrepiece of
successful management after bariatric surgery. High-risk
obese patients with a history of obstructive sleep apnoea
syndrome warrant admission to an intensive care unit [28].
Severe obesity predisposes patients to postoperative respi-
ratory complications such as atelectasis, particularly after
open abdominal surgery [29]. Even though laparoscopic
techniques decrease the severity of postoperative pain
experience, the need for effective postoperative analgesia
remains. Therefore, thoracic epidural analgesia is instru-
mental in allowing early mobilisation, unhindered deep
breathing and the use of incentive spirometry.
In conclusion, a high level of suspicion should be
present in the case of an unexpected postoperative
deterioration of the patient’s general condition. The lag-
time between onset of subtle symptoms and life-threatening
exacerbation (TTT) may be very short [4], as evidenced
again by this case. Such complications are best managed by
a multidisciplinary skilled team approach. Computed
tomography is mandatory to rule out pulmonary embolism
and bypass obstruction.
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